Glutathione Scientific References and Clinical Study Library

Search for glutathione scientific references and you will find a tangle of supplement marketing, forum claims and genuine papers that are hard to tell apart. This library separates them. It is a curated, evidence-ranked map of published research on glutathione (GSH), the tripeptide of glutamate, cysteine and glycine that cells make themselves. Every entry is labelled by study type, so you can see at a glance whether a finding comes from people, animals or cell models, and how far it can be trusted.

The central question running through this research is deceptively simple: can swallowing glutathione raise glutathione in the body? Early work said probably not; later trials said yes; a recent pooled analysis says the data are still inconclusive. Reading the primary papers, not summaries of them, is the only reliable way to judge. Use this page as your starting point, then open the sources.

Medical disclaimer. This page is educational and does not give individual medical advice. A published reference does not by itself prove that a supplement is effective or safe. Talk to a qualified clinician before using glutathione or any supplement, especially if you are pregnant, take medicines or have a medical condition.

How This Glutathione Scientific References Library Is Organized

Entries are grouped by evidence type, roughly from strongest to weakest for answering a clinical question: systematic reviews and meta-analyses, randomized controlled trials (RCTs), observational human studies, pharmacokinetic studies, safety and toxicology data, mechanistic studies, and preclinical studies. Human evidence always appears before animal or laboratory evidence.

Three rules guided selection. First, each reference had to be traceable to a PubMed record, a DOI, or an official publisher or registry page. Second, no finding is reported unless the abstract or full text was opened for this review. Third, where a study is small, short, industry-linked or uses surrogate markers such as blood glutathione, we say so. Where an entry's details have not yet been extracted, the table says "not yet extracted" rather than guessing.

For background on what the molecule is, see our glutathione identity guide. Related sections cover mechanisms of action, human evidence, dosage, quality and choosing a supplement, safety and interactions. The full overview lives in the Glutathione Master Thesis.

Systematic Reviews

Two systematic reviews are central. Dilokthornsakul and colleagues searched five databases to October 2017 for clinical studies of glutathione and skin in healthy volunteers [7]. They included four studies (three placebo-controlled RCTs and one single-arm trial), using oral doses of 250 to 500 mg per day or a topical 2.0% oxidized glutathione. Skin melanin index fell in sun-exposed areas with 500 mg per day orally and with the topical product, but not in sun-protected areas. Non-serious adverse events were reported. The authors judged the evidence inconclusive because of study quality and inconsistent findings.

The second review, below, pairs a systematic review with a meta-analysis.

Meta-Analyses

The only pooled analysis located for this update is Mangkalopakorn and colleagues (2024, published in the 2025 volume) [6]. Five RCTs met the inclusion criteria and three contributed to the meta-analysis. For erythrocyte glutathione the pooled standardized mean difference was 0.74 (95% CI −0.44 to 1.91; P = 0.22); for plasma it was 0.44 (95% CI −0.21 to 1.09; P = 0.19). Neither was statistically significant. The authors noted a high risk of bias in selective reporting, because several trials measured glutathione in multiple ways, and suggested that higher doses and longer durations might matter.

Two cautions apply. Three trials is a very small base, and confidence intervals this wide are compatible with both no effect and a sizeable one. This is also why a single positive trial, such as [1], and a null pooled result can both be true descriptions of an uncertain field.

Randomized Controlled Trials: Glutathione Clinical Studies

The RCT literature on oral glutathione is small, uses mostly healthy volunteers, and relies heavily on blood biomarkers rather than clinical outcomes.

Richie and colleagues (2015) randomized 54 non-smoking healthy adults to 250 mg, 1,000 mg or placebo daily for six months [1]. At the higher dose, glutathione rose about 30 to 35% in erythrocytes, plasma and lymphocytes and 260% in buccal cells, and the oxidized-to-reduced glutathione ratio fell. Levels returned toward baseline after a one-month washout. Immune markers were secondary outcomes in a subset, so those results are hypothesis-generating. The study used a branded commercial glutathione, and the manufacturer promoted it; readers should check the paper's funding and disclosure statements.

Allen and Bradley (2011) gave 40 healthy adults 500 mg twice daily or placebo for four weeks and found no significant change in oxidative stress biomarkers, including glutathione status [3]. The shorter duration and different measures may partly explain the contrast with [1].

Schmitt and colleagues (2015) ran a randomized crossover study in 20 volunteers with metabolic syndrome, comparing N-acetylcysteine, conventional oral glutathione and a novel sublingual form across 21-day periods [5]. The authors reported the sublingual form as superior; because it was a new formulation under evaluation, independent replication would be valuable.

Lai and colleagues (2020) randomized 61 people with liver cirrhosis to oral glutathione 500 mg per day, vitamin B6 or placebo for 12 weeks, with long follow-up [10]. Neither treatment produced statistically significant effects on oxidative stress indicators during the intervention (summary taken from a secondary source; confirm in the paper).

Other randomized or controlled trials sit in this library for completeness, with findings to be extracted at the next review: oral glutathione in elderly adults with type 2 diabetes [11], a three-week trial on insulin sensitivity in obese men [12], oral glutathione and growth in children with cystic fibrosis [13], and two Thai skin trials already pooled in [7] [8, 9].

Observational Human Studies

Observational evidence mostly shows association and mechanism, not benefit from supplements. Sekhar and colleagues compared eight older and eight younger adults using stable-isotope infusions and found lower red-blood-cell glutathione synthesis in the older group [15]. In the same report, two weeks of cysteine and glycine supplementation in the older group raised glutathione concentration by 94.6% and lowered plasma oxidative stress markers. This is a small, mechanistic physiology study; it concerns precursors, not glutathione capsules, and it does not show clinical benefit.

Honda and colleagues' open-label, single-arm pilot in non-alcoholic fatty liver disease is listed as an uncontrolled study [14]; without a control group it cannot separate treatment effects from natural variation.

Pharmacokinetic Studies in Oral Glutathione Research

Pharmacokinetics explains why the field was divided. In an early human study, a single 3 g oral dose did not raise circulating glutathione to a clinically useful extent, and the authors attributed this to breakdown by intestinal and hepatic γ-glutamyltransferase [4]. Later trials used repeated dosing over weeks or months and measured intracellular compartments [1, 2]. A 2018 pilot of liposomal glutathione at 500 and 1,000 mg per day in 12 healthy adults reported rises in blood glutathione and falls in markers such as plasma 8-isoprostane (−35%) and the oxidized-to-reduced ratio (−20%), but with no dose differences and limited statistical power [2]. Liposomal and sublingual products need larger, independent, placebo-controlled testing.

Safety and Toxicology Studies

Dedicated long-term toxicology literature in humans is thin. What exists is indirect: trials above generally monitored adverse events over weeks to months, and the skin review noted non-serious events [7]. The 2025 meta-analysis cites an FDA GRAS notice inventory entry for glutathione (GRN 293) [6]; its details were not individually reviewed here and should be confirmed at the source. Intravenous or injected glutathione for skin lightening is a separate matter: it is not an approved use, regulators have issued warnings, and its risk profile cannot be inferred from oral trials. Check current regulator notices directly.

Mechanistic Studies

Reviews of biochemistry describe how cells synthesize glutathione in two enzyme steps and use it for redox buffering, detoxification and immune regulation [17, 18]. Measurement papers explain why plasma values are a poor proxy for tissue stores, since plasma holds only a small, rapidly turning-over fraction [16]. These sources establish plausibility, not clinical effect.

Preclinical Studies

Animal and laboratory work gave the first evidence for oral absorption. In rats fed glutathione-supplemented diets, Hagen and colleagues found that gut removal occurred mainly in the jejunum and that brush-border enzymes and uptake systems did not remove all ingested glutathione [19]. Rodent results do not transfer directly to people, whose intestinal enzymes and dosing contexts differ. Preclinical findings should never be read as established human benefits.

Study Table: Year, Design, Population and Dose

DOI, PubMed and Official Links

Links below were opened or cross-checked during this review. Where only a PubMed or PMC page is given, no DOI was confirmed.

1. Richie JP Jr, Nichenametla S, Neidig W, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr 2015;54(2):251–263. DOI: 10.1007/s00394-014-0706-z. PubMed: https://pubmed.ncbi.nlm.nih.gov/24791752/
2. Sinha R, Sinha I, Calcagnotto A, et al. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. Eur J Clin Nutr 2018;72(1):105–111. DOI: 10.1038/ejcn.2017.132. PubMed: https://pubmed.ncbi.nlm.nih.gov/28853742/
3. Allen J, Bradley RD. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. J Altern Complement Med 2011;17(9):827–833. DOI: 10.1089/acm.2010.0716. https://pmc.ncbi.nlm.nih.gov/articles/PMC3162377/
4. Witschi A, Reddy S, Stofer B, Lauterburg BH. The systemic availability of oral glutathione. Eur J Clin Pharmacol 1992;43(6):667–669. DOI: 10.1007/BF02284971.
5. Schmitt B, Vicenzi M, Garrel C, Denis FM. Effects of N-acetylcysteine, oral glutathione (GSH) and a novel sublingual form of GSH on oxidative stress markers: a comparative crossover study. 2015. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536296/
6. Mangkalopakorn P, Segsarnviriya C, Keeratipranon M, Maiprasert M. Glutathione levels after glutathione supplementation: a systematic review and meta-analysis. J Curr Sci Technol 2025;15(1):90. DOI: 10.59796/jcst.V15N1.2025.90.
7. Dilokthornsakul W, Dhippayom T, Dilokthornsakul P. The clinical effect of glutathione on skin color and other related skin conditions: a systematic review. J Cosmet Dermatol 2019;18(3):728–737. PMID 30895708.
8. Arjinpathana N, Asawanonda P. Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study. J Dermatolog Treat 2012;23(2):97–102. DOI: 10.3109/09546631003801619 (as cited in [6]).
9. Weschawalit S, Thongthip S, Phutrakool P, Asawanonda P. Glutathione and its antiaging and antimelanogenic effects. Clin Cosmet Investig Dermatol 2017;10:147–153. DOI: 10.2147/CCID.S128339 (as cited in [6]).
10. Lai CY, Cheng SB, Lee TY, et al. Impact of glutathione and vitamin B-6 in cirrhosis patients: a randomized controlled trial and follow-up study. Nutrients 2020;12(7):1978. DOI: 10.3390/nu12071978 (as cited in [6]).
11. Kalamkar S, Acharya J, Kolappurath Madathil A, et al. Randomized clinical trial of how long-term glutathione supplementation offers protection from oxidative damage and improves HbA1c in elderly type 2 diabetic patients. Antioxidants 2022;11(5):1026. DOI: 10.3390/antiox11051026 (as cited in [6]).
12. Søndergård SD, Cintin I, Kuhlman AB, et al. The effects of 3 weeks of oral glutathione supplementation on whole body insulin sensitivity in obese males with and without type 2 diabetes: a randomized trial. Appl Physiol Nutr Metab 2021;46(9):1133–1142. DOI: 10.1139/apnm-2020-1099 (as cited in [6]).
13. Visca A, Bishop CT, Hilton S, Hudson VM. Oral reduced L-glutathione improves growth in pediatric cystic fibrosis patients. J Pediatr Gastroenterol Nutr 2015;60(6):802–810. DOI: 10.1097/MPG.0000000000000738 (as cited in [6]).
14. Honda Y, Kessoku T, Sumida Y, et al. Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study. BMC Gastroenterol 2017;17:96. DOI: 10.1186/s12876-017-0652-3 (as cited in [6]).
15. Sekhar RV, Patel SG, Guthikonda AP, et al. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr 2011;94(3):847–853. https://pmc.ncbi.nlm.nih.gov/articles/PMC3155927/
16. Kleinman WA, Richie JP Jr. Status of glutathione and other thiols and disulfides in human plasma. Biochem Pharmacol 2000;60(1):19–29. DOI: 10.1016/s0006-2952(00)00293-8 (as cited in [6]).
17. Lu SC. Glutathione synthesis. Biochim Biophys Acta 2013;1830(5):3143–3153. DOI: 10.1016/j.bbagen.2012.09.008 (as cited in [6]).
18. Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med 2009;30(1–2):1–12. DOI: 10.1016/j.mam.2008.08.006 (as cited in [6]).
19. Hagen TM, Wierzbicka GT, Bowman BB, Aw TY, Jones DP. Fate of dietary glutathione: disposition in the gastrointestinal tract. Am J Physiol 1990;259(4 Pt 1):G530–G535. DOI: 10.1152/ajpgi.1990.259.4.G530. PubMed: https://pubmed.ncbi.nlm.nih.gov/2221063/

What the Library Shows, and What It Does Not

Taken together, the human evidence supports a narrow statement: some trials report higher blood glutathione after months of oral supplementation, others find no change, and pooled analysis is inconclusive. No reference here establishes treatment of any disease, and most trials are small, short and focused on biomarkers. Evidence gaps include long-term safety, independent trials of liposomal and sublingual products, trials with clinical outcomes, and larger studies in people with low baseline glutathione.

Before relying on any claim, open the original paper, check the sample size, the control group, the funding statement and whether the outcome is a lab marker or something you would notice in daily life. Then explore how to choose a quality supplement, review the safety page, and discuss your situation with a healthcare professional.

Frequently Asked Questions

Does this library prove glutathione supplements work? No. It lists research and rates how strong each source is. Several trials report changes in blood glutathione; none here establishes clinical benefit.

Why do trials disagree? They differ in dose, duration, product form, population and outcome measure. Small samples also make results unstable.

Is animal evidence enough? No. Rodent studies show what is biologically possible, not what happens in people.

Are the skin-lightening studies reliable? The systematic review judged them inconclusive [7]. Injectable products for this purpose are a distinct, higher-risk issue.

How was this page checked? Items were verified against PubMed, PMC and publisher pages where opened, and cross-checked against the reference list of [6] otherwise. A plagiarism checker has not yet been run on this text.